Rutgers Cancer Institute, along with its partner
RWJBarnabas Health
, offers the most advanced cancer treatment options including complex robotic surgery, clinical trials and novel therapeutics such as precision medicine, CAR T-Cell Therapy and other forms of immunotherapy.
|
|
|
Welcoming a New Nursing Leader
|
|
|
|
Carolyn Hayes, PhD, RN, NEA-BC will serve as the new Chief Nursing Officer, RWJBarnabas Health, Oncology Services and Rutgers Cancer Institute of New Jersey beginning this month. In these roles Dr. Hayes will be responsible for and have oversight of nursing at Rutgers Cancer Institute and the oncology service line related nursing across RWJ Barnabas Health. Working closely with nursing leadership and oncology services leadership she will ensure nursing excellence throughout our integrated cancer care model. She was most recently the president and executive director of the Greater Boston Nursing Collective, a cooperative organization devoted to advancing the research, teaching, practice and leadership of the nursing profession. Hayes previously served as associate chief of oncology, medical and integrative nursing, as well as associate chief of adult inpatient and integrative oncology nursing at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston.
|
|
Supporting a New Research Vision
|
|
|
|
A pair of Rutgers Cancer Institute of New Jersey physician-scientists are collaborating on national research projects that received $1.5 million in combined funding from the Oncology Research Information Exchange Network® (ORIEN) New Oncologic Visionary Awards (NOVA) program.
Shridar Ganesan, MD, PhD
,
associate director for translational science and chief of molecular oncology at Rutgers Cancer Institute, received $500,000 for his team’s project that aims to identify a novel biomarker that can help guide the use of immunotherapy for cancer patients. Dr. Ganesan, is also a professor of medicine and pharmacology at Rutgers Robert Wood Johnson Medical School and the Omar Boraie Chair in Genomic Science.
Andrew M. Evens, DO, MSc, FACP
,
associate director for clinical services and director of the Lymphoma Program at Rutgers Cancer Institute, is part of a larger team that received $1 million to examine poor-risk relapsed non-Hodgkin lymphoma subtypes. Evens is also the medical director of the oncology service line at RWJBarnabas Health and a professor of medicine at Rutgers Robert Wood Johnson Medical School.
Learn more
|
|
Understanding Gynecologic Cancers
|
|
|
|
September is Gynecologic Cancer Awareness Month. Rutgers Cancer Institute of New Jersey gynecologic oncologist
Mihae Song, MD
,
who is also an assistant professor of obstetrics, gynecology and reproductive sciences at Rutgers Robert Wood Johnson Medical School, shares information on symptoms
for cancers of the female reproductive system including ovarian cancer, cervical cancer, vulva cancer, and endometrial cancer. She also discusses applicable screening, preventative vaccination and the importance of ‘knowing your body.’
Learn more
|
|
|
|
As many children head back to school this month, Rutgers Cancer Institute of New Jersey Chief of Pediatric Hematology/Oncology
Peter Cole, MD
,
shares some important health reminders for youngsters. Whether children are battling cancer or not, Dr. Cole, who is also the Embrace Kids Foundation Endowed Chair in Pediatric Hematology / Oncology and a professor of pediatrics at Rutgers Robert Wood Johnson Medical School, notes a good diet, physical activity and regular doctor check-ups can help keep kids healthy.
Learn more
|
|
Leukemia: Not Just One Disease
|
|
|
|
An estimated 61,780 new cases of leukemia will be diagnosed in the United States this year, with some 2,000 cases in New Jersey, according to the American Cancer Society. Although leukemias are thought to occur in childhood, they can actually present at any age in both children and adults. However, not all leukemias are created equal.
Athena Kritharis, MD
,
hematologist/oncologist in the Hematologic Malignancies Program at Rutgers Cancer Institute of New Jersey and an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, shares some insight about this form of blood cancer.
Learn more
|
|
|
|
|
|
|
